Alison Gibson speaking at a conference table.

Throughout March, the University of Kentucky is spotlighting Women Making History during Women’s History Month. These women are leading their fields of research and impacting the lives of Kentuckians.

Jill Roberts, PhD, in her lab.

Feb. 28 is international Rare Disease Day. Kentucky has surprisingly high rates — almost 10 times the national average — of a rare condition called Moyamoya syndrome, which causes the internal carotid arteries in the brain to become narrow or blocked.

Congrats graphic

The University of Kentucky College of Medicine is pleased to announce the faculty, staff, and learners who were winners of the annual Mission, Vision, Pillar, and Enabler Awards.

Gurpreet Dhaliwal

The UK College of Medicine is excited to welcome Gurpreet Dhaliwal, MD, as the visiting professor delivering this year’s Alpha Omega Alpha (AOA) Humanities Lecture. 

Photo of Gregory A. Jicha, M.D., Ph.D.

The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of a promising drug known as lecanemab. Just a few weeks ago the U.S.

The Pat Summitt Foundation presenting a $25,000 check to UK's Sanders-Brown Center on Aging during the women's basketball game

The Pat Summitt Foundation presented a $25,000 grant to the University of Kentucky's Sanders-Brown Center on Aging (SBCoA)during the UK women’s basketball game against Auburn University on Thursday evening. The center is one of the nation’s top centers on aging, with a goal to preserve brain health and slow the progression of dementia.

woman holding her hands up making a heart shape

The University of Kentucky’s ninth annual Healthy Hearts for Women Symposium will bring in nationally recognized experts to raise awareness about the dangers of heart disease and educate attendees on prevention techniques.

Jessica Gebhardt

My name is Jessica Gebhardt, and I am a graduate student in Dr. Josh Morganti’s Lab studying the effects of dysregulated neuroinflammation following traumatic brain injury (TBI). TBI has personally impacted me and my family, and as a result I have been interested in furthering my understanding of the mechanisms underlying the injury for many years.

Mike Brown getting an infusion treatment.

The University of Kentucky is a site for the groundbreaking AHEAD study, the first-ever clinical trial to test the effect of lecanemab (investigational antibody) in people who have no cognitive symptoms of Alzheimer’s disease (AD), but in whom biomarker tests indicate amyloid is present in the brain, known as “preclinical” AD.

Donna Wilcock

Donna Wilcock, PhD, wears many hats at the University of Kentucky, all of which are roles that help advance education and research in the Commonwealth, particularly in the realm of Alzheimer’s disease. Dr. Wilcock is assistant dean for biomedicine at the UK College of Medicine, as well as associate director of Sanders-Brown Center on Aging. She is also the Robert P. and Mildred A.

College of medicine logo over white background

Our College of Medicine community,

Honoring Indigenous Peoples' Month

During Indigenous Peoples’ Month, the UK College of Medicine is highlighting historical figures who paved the way for an equitable future in medicine.

Sara Police working on her laptop

“For some reason, I really wanted fruit or savory food when I was going through treatment. Spicy, savory, salty food — that helped with my appetite,” recalls University of Kentucky chemistry doctoral student Yueming “Ronnie” Wu.

William Markesbery, MD

The University of Kentucky’s (UK) Sanders-Brown Center on Aging (SBCoA) will host its 12th annual Markesbery Symposium on Aging and Dementia this weekend. The event is named in honor and memory of the late William R. Markesbery, MD, founding director of the Sanders-Brown Center on Aging and Alzheimer's Disease Research Center.

Research poster presentation being given to a group of adults.

The University of Kentucky Sanders-Brown Center on Aging will hold the 12th annual Markesbery Symposium on Aging and Dementia on Nov. 18 and 19. The scientific session will take place from 11 a.m. until 4:30 p.m. Friday, Nov. 18, in the Lee T. Todd Building.

Donna Wilcock, PhD on Sept, 22, 2022.

Donna Wilcock, PhD, of the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) was awarded a $1.7 million National Institutes of Health grant for her lab’s exploration of adverse effects of two new Alzheimer’s disease drugs — aducanumab and lecanemab —​ which have been shown to slow the progression of cognitive decline.

Elizabeth Rhodus stretching an exercise band.

A CD player. Lavender-infused lotion. A weighted blanket. A roll of red tape. The last things you’d expect when it comes to Alzheimer’s care. But every item was chosen for a specific purpose: to help care for a person with Alzheimer’s disease and related dementias (ADRD) through their sense of hearing, smell, feel, sight and more.

OB-GYN and former BIRCWH scholar Rachel W. Miller, MD, and her colleague Jill Kolesar, PharmD, are co-directors of the Markey Cancer Center Molecular Tumor Board.

The University of Kentucky’s Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) program has received a five-year grant renewal — making this program over two decades old at the University of Kentucky.

12th Annual Markesbery Symposium on Aging and Dementia

We are pleased to announce the twelfth annual Markesbery Symposium for 2022, named in honor and memory of the late William R. Markesbery, MD, founding Director of the Sanders-Brown Center on Aging and Alzheimer's Disease Research Center. Dr.

Donna Wilcock, PhD on Sept, 22, 2022.

The Alzheimer’s Association welcomes the University of Kentucky’s Donna M. Wilcock, PhD, as the new editor-in-chief of Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association.